In order to promote liver disease related research at KUMC, the Phase III COBRE proposes to institute an annual Pilot Grants Program. The goals of this Pilot Grants Program are to support the career development of new investigators, allow established investigators to enter a new field, and promote collaborative interactions among the faculty. The topics supported will cover the broad area of liver diseases including basic, translational and clinical investigation. To achieve these goals we propose three specific aims: 1. To establish a Pilot Grants Program to fund promising new investigators in the area of liver disease research. 2. To have the Pilot Grants Program serve as a means to enhance communication and increase collaboration within the liver research community, between basic and clinical investigators, and between KUMC and KU Lawrence investigators, and 3. To assess the impact of the Pilot Grants Program on the grant recipients and the Liver Research Community at KU, and to use this information to modify and improve the program. We will further use this information to improve the Pilot Grants Program through a process of re-evaluation of practices and program modification. Our plan will be to award three $40,000 grants in the first year and then a combination of new and second year grants eventually for a total of five awards per year. We will introduce several innovative aspects of this Pilot Grants Program including an annual symposium in which the applicants propose their research to the broader liver research community, and an evaluation process in which the impact of the Pilot Grants Program on career development will be assessed. This program is expected to help grow the critical mass in NIH-funded liver disease research and position us to successfully compete for center funding at the completion of this award period.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
5P30GM118247-03
Application #
9536858
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2018-08-01
Budget End
2019-07-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Kansas
Department
Type
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
McGill, Mitchell R; Jaeschke, Hartmut (2018) Biomarkers of drug-induced liver injury: progress and utility in research, medicine, and regulation. Expert Rev Mol Diagn 18:797-807
Huck, Ian; Beggs, Kevin; Apte, Udayan (2018) Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice. Int J Toxicol 37:383-392
Jiang, Lu; Fang, Pingping; Septer, Seth et al. (2018) Inhibition of Mast Cell Degranulation With Cromolyn Sodium Exhibits Organ-Specific Effects in Polycystic Kidney (PCK) Rats. Int J Toxicol 37:308-326
Wang, Yifeng; Ding, Wen-Xing; Li, Tiangang (2018) Cholesterol and bile acid-mediated regulation of autophagy in fatty liver diseases and atherosclerosis. Biochim Biophys Acta Mol Cell Biol Lipids 1863:726-733
Wang, Shaogui; Wang, Hua; Ding, Wen-Xing (2018) Pyroptosis, A novel player for alcoholic hepatitis? Hepatology 67:1660-1662
Funk, Ryan S; Singh, Rakesh K; Winefield, Robert D et al. (2018) Variability in Potency Among Commercial Preparations of Berberine. J Diet Suppl 15:343-351
Du, Kuo; Ramachandran, Anup; Weemhoff, James L et al. (2018) Mito-tempo protects against acute liver injury but induces limited secondary apoptosis during the late phase of acetaminophen hepatotoxicity. Arch Toxicol :
Woolbright, Benjamin L; Jaeschke, Hartmut (2018) Is Keratin-18 only a Marker of Cell Death in Acute-On-Chronic Liver Failure? J Lab Precis Med 3:
McGreal, Steven R; Bhushan, Bharat; Walesky, Chad et al. (2018) Modulation of O-GlcNAc Levels in the Liver Impacts Acetaminophen-Induced Liver Injury by Affecting Protein Adduct Formation and Glutathione Synthesis. Toxicol Sci 162:599-610
Zhao, Jie; Adams, Abby; Roberts, Ben et al. (2018) Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice. Hepatology 67:1109-1126

Showing the most recent 10 out of 65 publications